Insider · CIK 0001506314
James Patrick Kelly
Files at NVAX (NOVAVAX INC). First filing -, latest -.
In brief
James Patrick Kelly files SEC Form 4 as CFO at NVAX (NOVAVAX INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; James Patrick Kelly has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 7, 2026 | NVAX NOVAVAX INC | MOption exercise Common Stock | +12,223 | $0.00 | $0 | 136,503 | Mar 9, 2026 |
| Mar 2, 2026 | NVAX NOVAVAX INC | AGrant or award Non-statutory Stock Option NQderivative | +194,000 | $0.00 | $0 | 194,000 | Mar 9, 2026 |
| Mar 7, 2026 | NVAX NOVAVAX INC | FTax withholding Common Stock | -5,904 | $9.98 | $59k | 130,599 | Mar 9, 2026 |
| Mar 7, 2026 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -12,223 | $0.00 | $0 | 0 | Mar 9, 2026 |
| Mar 3, 2026 | NVAX NOVAVAX INC | MOption exercise Common Stock | +43,167 | $0.00 | $0 | 145,130 | Mar 5, 2026 |
| Mar 3, 2026 | NVAX NOVAVAX INC | FTax withholding Common Stock | -20,850 | $9.49 | $198k | 124,280 | Mar 5, 2026 |
| Mar 3, 2026 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -43,167 | $0.00 | $0 | 86,333 | Mar 5, 2026 |
| Mar 1, 2026 | NVAX NOVAVAX INC | MOption exercise Common Stock | +58,666 | $0.00 | $0 | 130,299 | Mar 3, 2026 |
| Mar 1, 2026 | NVAX NOVAVAX INC | FTax withholding Common Stock | -28,366 | $10.14 | $288k | 101,963 | Mar 3, 2026 |
| Mar 1, 2026 | NVAX NOVAVAX INC | DDisposition to issuer Restricted Stock Unitsderivative | -58,666 | $0.00 | $0 | 58,666 | Mar 3, 2026 |
| Mar 2, 2026 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +129,500 | $0.00 | $0 | 129,500 | Mar 3, 2026 |
| Mar 2, 2026 | NVAX NOVAVAX INC | AGrant or award Non-statutory Stock Option NQderivative | +194,000 | $9.09 | $1.8M | 194,000 | Mar 3, 2026 |
| Mar 7, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +12,223 | $0.00 | $0 | 75,155 | Mar 11, 2025 |
| Mar 7, 2025 | NVAX NOVAVAX INC | FTax withholding Common Stock | -5,904 | $8.34 | $49k | 69,251 | Mar 11, 2025 |
| Mar 7, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -12,223 | $0.00 | $0 | 12,223 | Mar 11, 2025 |
| Mar 3, 2025 | NVAX NOVAVAX INC | AGrant or award 2025 Non-statutory Stock Option NQderivative | +194,500 | $7.87 | $1.5M | 194,500 | Mar 5, 2025 |
| Mar 3, 2025 | NVAX NOVAVAX INC | AGrant or award 2025 Restricted Stock Units RSUderivative | +129,500 | $0.00 | $0 | 129,500 | Mar 5, 2025 |
| Mar 1, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +58,667 | $0.00 | $0 | 91,269 | Mar 4, 2025 |
| Mar 1, 2025 | NVAX NOVAVAX INC | FTax withholding Common Stock | -28,337 | $8.33 | $236k | 62,932 | Mar 4, 2025 |
| Mar 1, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -58,667 | $0.00 | $0 | 117,333 | Mar 4, 2025 |
| Dec 31, 2024 | NVAX NOVAVAX INC | MOption exercise Common Stock | +35,000 | $0.00 | $0 | 49,508 | Jan 3, 2025 |
| Dec 31, 2024 | NVAX NOVAVAX INC | FTax withholding Common Stock | -16,906 | $8.04 | $136k | 32,602 | Jan 3, 2025 |
| Dec 31, 2024 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -35,000 | $0.00 | $0 | 0 | Jan 3, 2025 |
Questions about James Patrick Kelly
Answered from the filings on this page, as of the latest one.
Is James Patrick Kelly buying or selling?
James Patrick Kelly has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did James Patrick Kelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James Patrick Kelly has 0.
Where does James Patrick Kelly file Form 4?
James Patrick Kelly has filed Form 4 at NVAX (NOVAVAX INC) as EVP, CFO and Treasurer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.